Table 3 Distribution of ROR score and PAM50 subtype according to HER2 status

From: Prosigna Risk of Recurrence score and intrinsic subtypes are associated with adjuvant anthracycline chemotherapy benefit in high-risk breast cancer

 

Total

HER2-negative

HER2-positive

 

N

Col %

N

Col %

N

Col %

 

1140

 

826

 

314

 

ROR score

 ≤ 51

470

41

404

49

66

21

 52-71

443

39

322

39

121

39

 ≥ 72

227

20

100

12

127

40

PAM50 subtype

 HER2-enriched

322

28

65

8

257

82

 Basal-like

353

31

338

41

15

5

 Luminal B

188

16

171

21

17

5

 Luminal A

277

24

252

31

25

8

Back to article page